nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are there alternatives to mortality as an endpoint in clinical trials of atrial fibrillation?
|
George Wyse, D |
|
2004 |
|
2S |
p. 41-44 4 p. |
artikel |
2 |
Atrial fibrillation endpoints: hospitalization
|
Ruskin, Jeremy N |
|
2004 |
|
2S |
p. 31-35 5 p. |
artikel |
3 |
Diagnostic information in implantable devices that pertain to endpoints in atrial fibrillation studies
|
Mehra, Rahul |
|
2004 |
|
2S |
p. 64-69 6 p. |
artikel |
4 |
Editorial board
|
|
|
2004 |
|
2S |
p. 70- 1 p. |
artikel |
5 |
Mortality as an endpoint in atrial fibrillation 1 1 Processed by a guest editor.
|
Beyerbach, Daniel M |
|
2004 |
|
2S |
p. 8-19 12 p. |
artikel |
6 |
Overview of endpoints in atrial fibrillation studies
|
George Wyse, D |
|
2004 |
|
2S |
p. 3-7 5 p. |
artikel |
7 |
Overview of symposium: outcomes in AF trials
|
Mehra, Rahul |
|
2004 |
|
2S |
p. 1-2 2 p. |
artikel |
8 |
Quality of life as an endpoint for atrial fibrillation research: pitfalls and practice
|
Newman, David |
|
2004 |
|
2S |
p. 20-26 7 p. |
artikel |
9 |
Rhythm control in atrial fibrillation: endpoints for device-based trials
|
Gillis, Anne M |
|
2004 |
|
2S |
p. 52-57 6 p. |
artikel |
10 |
Sample size estimates for atrial fibrillation endpoints
|
Warman, Eduardo N |
|
2004 |
|
2S |
p. 58-63 6 p. |
artikel |
11 |
Stroke and bleeding as an endpoint in atrial fibrillation studies
|
Trang Dinh, N.H |
|
2004 |
|
2S |
p. 27-30 4 p. |
artikel |
12 |
Symptomatic arrhythmia recurrence as an outcome in clinical trials of antiarrhythmic drug therapy
|
Pritchett, Edward L.C |
|
2004 |
|
2S |
p. 36-40 5 p. |
artikel |
13 |
Ventricular rate control as an endpoint for treatment of atrial fibrillation
|
Wood, Mark A |
|
2004 |
|
2S |
p. 45-51 7 p. |
artikel |